Openings between defective endothelial cells explain tumor vessel leakiness.
Leakiness of blood vessels in tumors may contribute to disease progression and is key to certain forms of cancer therapy, but the structural basis of the leakiness is unclear. We sought to determine whether endothelial gaps or transcellular holes, similar to those found in leaky vessels in inflammation, could explain the leakiness of tumor vessels. Blood vessels in MCa-IV mouse mammary carcinomas, which are known to be unusually leaky (functional pore size 1.2-2 microm), were compared to vessels in three less leaky tumors and normal mammary glands. Vessels were identified by their binding of intravascularly injected fluorescent cationic liposomes and Lycopersicon esculentum lectin and by CD31 (PECAM) immunoreactivity. The luminal surface of vessels in all four tumors had a defective endothelial monolayer as revealed by scanning electron microscopy. In MCa-IV tumors, 14% of the vessel surface was lined by poorly connected, overlapping cells. The most superficial lining cells, like endothelial cells, had CD31 immunoreactivity and fenestrae with diaphragms, but they had a branched phenotype with cytoplasmic projections as long as 50 microm. Some branched cells were separated by intercellular openings (mean diameter 1.7 microm; range, 0.3-4.7 microm). Transcellular holes (mean diameter 0.6 microm) were also present but were only 8% as numerous as intercellular openings. Some CD31-positive cells protruded into the vessel lumen; others sprouted into perivascular tumor tissue. Tumors in RIP-Tag2 mice had, in addition, tumor cell-lined lakes of extravasated erythrocytes. We conclude that some tumor vessels have a defective cellular lining composed of disorganized, loosely connected, branched, overlapping or sprouting endothelial cells. Openings between these cells contribute to tumor vessel leakiness and may permit access of macromolecular therapeutic agents to tumor cells.
Hashizume
H
H
Cardiovascular Research Institute and Department of Anatomy, University of California, San Francisco, California 94143-0130, USA.
Baluk
P
P
Morikawa
S
S
McLean
J W
JW
Thurston
G
G
Roberge
S
S
Jain
R K
RK
McDonald
D M
DM
D000818:Animals; D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology; D002199:Capillary Permeability; D004730:Endothelium, Vascular / Q000473:pathology*; D005110:Extracellular Space / Q000502:physiology*; D005260:Female; D008297:Male; D015674:Mammary Neoplasms, Animal / Q000098:blood supply* / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D008856:Microscopy, Fluorescence; D009368:Neoplasm Transplantation